The HBsAg test looks for hepatitis B surface antigen, a protein from the outer coat of the hepatitis B virus. Unlike an antibody test, it detects a piece of the virus itself, which means a positive result indicates the virus is present in your body right now rather than at some point in the past.
That directness makes it the anchor of hepatitis B testing, but the result rarely arrives alone. In this article you will learn what the protein signals, how it combines with the two antibody tests that accompany it, what the difference between acute and chronic infection means for you, and what recent research says about clearing the antigen with newer treatments.
What the HBsAg test measures
Hepatitis B is a virus that infects liver cells. As it replicates, it produces large quantities of surface antigen, far more than is needed to build new virus particles, and this excess spills into the bloodstream. A laboratory can detect it about one to two weeks after infection begins, often before any symptoms appear and before the immune system has produced antibodies.
Because the antigen is part of the virus rather than a record of the immune response, its presence means active infection. Its disappearance means the infection has been brought under control, either by the immune system or, less often, by treatment.
The sample is a routine blood draw with no fasting requirement, and results are typically available within one to three days. They are reported as positive or negative, sometimes described as reactive or non-reactive.
The three tests that make up the panel
Current guidance recommends testing three markers together, because any one of them alone leaves the picture incomplete.
| Marker | What it is | What a positive result indicates |
|---|---|---|
| HBsAg | Surface antigen, part of the virus | Current infection, whether recent or long-standing |
| Anti-HBs | Antibody against the surface antigen | Immunity, either from vaccination or from a resolved infection |
| Anti-HBc | Antibody against the core protein | Past or present natural infection; vaccination does not produce it |
That last row is the one that distinguishes vaccination from a real infection. Someone vaccinated has anti-HBs but not anti-HBc; someone who caught and cleared the virus has both.
Why your doctor ordered this test
Since 2023, United States guidance has recommended that every adult be tested for hepatitis B at least once, regardless of risk. Seeing this on your panel is therefore usually routine preventive screening rather than a sign that anyone suspects something.
- One-time screening for all adults aged eighteen and over.
- Every pregnancy, so that a baby born to a positive mother can be protected within hours of birth.
- Before starting medications that suppress the immune system, since dormant infection can reactivate.
- Investigation of abnormal liver enzymes or unexplained jaundice. See our ALT liver enzyme guide.
- Before blood or organ donation, and in people undergoing hemodialysis.
- Alongside screening for related infections, including our anti-HCV test and our HIV test.
How to read your HBsAg result
| HBsAg | Anti-HBs | Anti-HBc | Usual interpretation |
|---|---|---|---|
| Negative | Negative | Negative | Never infected and not immune; vaccination is recommended |
| Negative | Positive | Negative | Immune through vaccination |
| Negative | Positive | Positive | Immune after recovering from a past infection |
| Positive | Negative | Positive | Current infection; further tests determine whether it is acute or chronic |
Other combinations exist and can be harder to interpret, particularly a positive core antibody with everything else negative. That pattern can reflect a distant resolved infection, a false reaction, or occasionally a hidden low-level infection, and it is followed up rather than dismissed.
Acute or chronic
The distinction rests on time rather than on the number. If surface antigen is still present six months after it first appeared, the infection is called chronic. If it clears before then, the infection was acute and has resolved. Most healthy adults who catch hepatitis B clear it; infection acquired in infancy becomes chronic far more often, which is why newborn vaccination matters so much.
What follows a positive result
A positive surface antigen result is not an emergency and does not mean liver damage has occurred. It is the start of an assessment.
- Additional viral tests, including HBV DNA to measure how much virus is present and HBeAg to gauge how actively it is replicating.
- Liver enzymes, a platelet count and an albumin blood test to assess liver function and any scarring.
- An ultrasound or elastography scan of the liver.
- Testing and vaccination for close contacts and household members.
- A decision about whether antiviral treatment is needed now or whether monitoring is appropriate.
Many people with chronic hepatitis B never need treatment and simply attend regular monitoring. Those who do take antivirals usually take one tablet daily, which suppresses the virus effectively and reduces the long-term risk of liver scarring and liver cancer. Our overview of hepatitis B symptoms, causes and treatments covers the condition more fully.
When to see a doctor
- Arrange follow-up within a week or two of a positive result, so the full panel and liver assessment can be completed.
- Seek prompt care for yellowing of the eyes or skin, dark urine, pale stools, abdominal swelling, persistent vomiting or confusion.
- Contact your clinician before starting any immune-suppressing medication or chemotherapy if you have ever tested positive for hepatitis B markers, since reactivation is preventable but serious.
- Book a routine review if you are negative for all three markers, since vaccination is safe, effective and worth having.
Latest scientific advances
Two lines of research over the past three years matter to anyone reading this result: who gets tested, and whether the antigen can be cleared with treatment.
Screening became universal for adults
In 2023 the Centers for Disease Control and Prevention issued formal recommendations that every adult aged eighteen and over be tested for hepatitis B at least once, using the three-test panel, and be able to request testing without having to explain why. What this means for you is a change in framing. A hepatitis B panel appearing on your lab report is now routine preventive care, not an indication that your doctor suspects anything about your history.
Clearing the antigen is becoming possible, for some
Losing surface antigen, sometimes called a functional cure, has long been considered close to unreachable with existing drugs. A 2026 report of two large trials of a new injected medicine found that roughly one in five people with chronic hepatitis B cleared the antigen and kept the virus undetectable after stopping their usual tablets, while nobody receiving a dummy treatment did. That is a meaningful result, though it also means four in five did not reach that goal. It is worth raising with a liver specialist rather than treating as a settled option.
A falling number is not the same as a cure
A 2025 systematic review pooled nineteen trials involving nearly eighteen hundred people and found that most newer hepatitis B drugs lowered surface antigen only temporarily. Lasting clearance was uncommon, and the virus returned in roughly one in five people after treatment stopped. For a patient watching their own numbers, the practical lesson is important: a falling antigen level during treatment is encouraging but not proof of cure, so prescribed therapy and monitoring appointments both still matter.
Glossary
| Term | Definition |
|---|---|
| HBsAg | Hepatitis B surface antigen, a protein from the virus’s outer coat. Its presence means current infection. |
| Antigen | A substance the immune system recognizes as foreign, here a piece of the virus itself. |
| Anti-HBs | Antibody against the surface antigen, showing immunity from vaccination or recovery. |
| Anti-HBc | Antibody against the core protein, produced only after a real infection, never by vaccination. |
| HBV DNA | The genetic material of the virus, measured to show how much virus is present. |
| Chronic infection | Surface antigen still detectable six months or more after it first appeared. |
| Functional cure | Lasting loss of surface antigen with the virus staying undetectable after treatment stops. |
| Reactivation | A dormant infection becoming active again, usually when the immune system is suppressed. |
| Elastography | A scan that measures liver stiffness as an indication of scarring, without a biopsy. |
Frequently asked questions
What does a positive HBsAg test mean?
It means hepatitis B virus is present in your body at the moment the sample was taken. Unlike antibody tests, this one detects part of the virus itself, so it reflects current infection rather than past exposure. It does not tell you how long you have had it, how much liver damage there is, or whether treatment is needed. Those questions are answered by the rest of the panel, viral load testing and liver assessment.
What does a negative HBsAg result mean?
It means no hepatitis B surface antigen was detected, so you do not have an active infection. On its own it does not tell you whether you are immune. That depends on the antibody results in the same panel: surface antibody indicates protection from vaccination or recovery, while core antibody indicates a real infection in the past. If all three markers are negative, vaccination is recommended.
Does a positive result mean I will develop liver disease?
Not necessarily. Many people with chronic hepatitis B live normal lives with normal liver function and never need treatment, attending regular monitoring instead. The long-term risks of scarring and liver cancer are real but are substantially reduced by monitoring and, when indicated, daily antiviral tablets. What matters most is staying in follow-up rather than the single result itself.
Can HBsAg become negative over time?
Yes. Most healthy adults who catch hepatitis B clear the antigen within six months, and the infection resolves. In chronic infection, spontaneous clearance also happens but slowly, at a rate of roughly one percent of people each year. Newer treatments under study aim to make clearance more achievable, though most people on current therapy do not reach it.
Is hepatitis B the same as hepatitis C?
No. They are unrelated viruses with different tests, different treatments and different outcomes. Hepatitis B is prevented by a vaccine and usually controlled rather than cured; hepatitis C has no vaccine but is cured in most people by a short course of tablets. They are often screened together because they share some transmission routes, and both are tested for before treatments that suppress the immune system.
Should my family be tested?
Yes. Household members and sexual partners of someone with a positive result should be tested and, if not immune, vaccinated. The virus spreads through blood and body fluids, not through sharing food, hugging or casual contact. Babies born to a person with hepatitis B can be protected very effectively if they receive vaccine and immune globulin within hours of birth, which is why testing is routine in pregnancy.
Sources
- MedlinePlus, National Library of Medicine — Hepatitis Virus Panel — MedlinePlus Medical Encyclopedia, reviewed 2024 — medlineplus.gov
- Centers for Disease Control and Prevention — Clinical Testing and Diagnosis for Hepatitis B — CDC Hepatitis B, reviewed 2026 — cdc.gov
- Cleveland Clinic — Hepatitis B Surface Antigen (HBsAg) Screen — Cleveland Clinic Health Library, reviewed 2025 — my.clevelandclinic.org
- Conners EE, Panagiotakopoulos L, et al — Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023 — MMWR Recommendations and Reports, 2023 — doi.org/10.15585/mmwr.rr7201a1
- Hou J, Lim SG, et al — Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection — New England Journal of Medicine, 2026 — doi.org/10.1056/NEJMoa2515131
- Chen J, Ji D, et al — Functional Cure with New Antiviral Therapy for Hepatitis B Virus: A Systematic Review and Meta-Analysis — Hepatology International, 2025 — doi.org/10.1007/s12072-025-10823-5
Further reading
- Compare the antibody screen used for the other blood-borne hepatitis virus in our anti-HCV test results guide.
- Understand the condition behind this marker by reading our hepatitis B overview.
- Interpret the liver enzyme most often checked alongside it with our AST blood test guide.
- Review the protein that reflects long-term liver function in our albumin test results guide.
- Explore the other infection screened in the same panel using our HIV test results guide.
Understand your lab results with BloodSense
Three hepatitis B markers, each positive or negative, produce eight possible combinations, and the difference between immunity and infection is not obvious from the words on the page. BloodSense reads your full report and explains, in plain language, what the surface antigen and the two antibodies mean together, and how your liver enzymes fit alongside them. It helps you understand your own panel before your appointment. It does not diagnose conditions and does not replace your clinician.
